ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Gusberg Heads ACS, With Scanlon As President Elect; MDA honors Holland, D’Angio, Landing

November 16, 1979

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Obituary: Ben Horowitz, 96, Led City of Hope For 32 Years

October 8, 2010

41 CCOPs Reported For Recompetition

February 23, 1990

NCI’s caBIG to Expand For Clinical Informatics Projects.

January 26, 2007

NCAB Members Skeptical On NCI Reorganization; King Has “Alterative;” Terry T Head Centers

January 27, 1978